本页面由Tiger Trade Technology Pte. Ltd.提供服务

Olema Pharmaceuticals, Inc.

7.36
-0.4600-5.88%
成交量:101.87万
成交额:759.27万
市值:6.41亿
市盈率:-3.46
高:7.77
开:7.77
低:7.33
收:7.82
52周最高:36.26
52周最低:6.65
股本:8,715.70万
流通股本:7,188.81万
量比:1.01
换手率:1.42%
股息:- -
股息率:- -
每股收益(TTM):-2.1289
每股收益(LYR):-1.8700
净资产收益率:-52.74%
总资产收益率:-31.82%
市净率:1.49
市盈率(LYR):-3.94

数据加载中...

2024/01/08

重要事件披露

Form 8-K - Current report
2024/01/08

重要事件披露

Form 8-K - Current report
2024/01/06

重要事件披露

Form 8-K - Current report
2023/12/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/06

重要事件披露

Form 8-K - Current report
2023/12/06

重要事件披露

Form 8-K - Current report
2023/11/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/28

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]